Janus Henderson Group plc 13D and 13G filings for Mirum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 12:11 pm Purchase |
2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,581,642 9.500% |
101,358![]() (+2.26%) |
Filing |
2024-11-14 12:55 pm Sale |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,480,284 9.400% |
-508,463![]() (-10.19%) |
Filing |
2024-07-10 1:12 pm Purchase |
2024-06-28 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
JANUS HENDERSON GROUP PLC JHG |
4,988,747 10.600% |
4,988,747![]() (New Position) |
Filing |